Q1 2025 · 13F-HR
Ally Bridge Group (NY) LLCholdings as filed
Filed 2025-05-15 · accession 0000950123-25-005586
$110.9M
Reported value
28
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $12.4M | 11.2% | 281,139 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC - ADR | $8.8M | 7.96% | 139,067 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $8.6M | 7.76% | 120,449 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $8.4M | 7.58% | 72,113 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $6.6M | 5.92% | 127,932 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $6.6M | 5.92% | 74,192 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $6.5M | 5.85% | 85,110 | Common | SOLE |
| 05464T904 | — | AXSOME THERAPEUTICS INC | $5.8M | 5.26% | 50,000 | Common | NONE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $4.3M | 3.89% | 686,219 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $3.6M | 3.26% | 95,582 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS-ADR | $3.5M | 3.15% | 243,086 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $3.3M | 3.01% | 169,774 | Common | SOLE |
| N5749R100 | 2GH | MERUS NV | $3.3M | 2.96% | 77,896 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $3.3M | 2.95% | 2,056,637 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $3.2M | 2.92% | 132,298 | Common | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $2.3M | 2.12% | 777,020 | Common | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $2.3M | 2.11% | 132,222 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $2.3M | 2.11% | 69,603 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $2.3M | 2.06% | 390,143 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $2.3M | 2.04% | 102,650 | Common | SOLE |
| 28036F905 | — | EDGEWISE THERAPEUTICS INC | $2.2M | 1.98% | 100,000 | Common | NONE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $2.2M | 1.98% | 81,292 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $1.5M | 1.32% | 80,584 | Common | SOLE |
| 00032Q104 | WHWK | WHITEHAWK THERAPEUTICS INC | $1.5M | 1.31% | 817,939 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $1.0M | 0.94% | 59,723 | Common | SOLE |
| 74346M406 | PMNEUR | PROMIS NEUROSCIENCES INC | $1.0M | 0.93% | 1,484,699 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $997,369 | 0.90% | 107,244 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $708,358 | 0.64% | 1,157,448 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.